These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24044627)

  • 1. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L; Daskilewicz K; McIntyre J; Bekker LG
    J Int AIDS Soc; 2013 Sep; 16(1):18649. PubMed ID: 24044627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy.
    Mnyani CN; McIntyre JA; Myer L
    J Acquir Immune Defic Syndr; 2012 Jul; 60(3):260-4. PubMed ID: 22487589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon.
    Sagnia B; Mbakop Ghomsi F; Gutierrez A; Sosso S; Kamgaing R; Nanfack AJ; Nji N; Ambada G; Lissom A; Tchouangueu TF; Ngu Ndengkoh L; Domkam I; Nchinda G; Ndjolo A
    AIDS Res Ther; 2020 Aug; 17(1):53. PubMed ID: 32799909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa.
    Patten GE; Wilkinson L; Conradie K; Isaakidis P; Harries AD; Edginton ME; De Azevedo V; van Cutsem G
    J Int AIDS Soc; 2013 Jul; 16(1):18518. PubMed ID: 23830642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.
    Ciaranello AL; Myer L; Kelly K; Christensen S; Daskilewicz K; Doherty K; Bekker LG; Hou T; Wood R; Francke JA; Wools-Kaloustian K; Freedberg KA; Walensky RP
    PLoS One; 2015; 10(3):e0117751. PubMed ID: 25756498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes.
    Van Turha L; Maharaj K; Rose A; Boeke C; Peter TF; Vojnov L; Quevedo J; Tsibolane Y
    S Afr Med J; 2020 Jan; 110(2):126-131. PubMed ID: 32657683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C; Rose CE; Inzaule S; Desai MA; Otieno F; Humwa F; Akoth B; Omolo P; Chen RT; Kebede Y; Samandari T
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of BD FACSPresto™ point of care CD4 analyzer to enumerate CD4 counts for monitoring HIV infected individuals in Nigeria.
    Negedu-Momoh OR; Jegede FE; Yakubu A; Balogun O; Abdullahi M; Badru T; Oladele EA; Agbakwuru C; Khamofu H; Torpey K
    PLoS One; 2017; 12(5):e0178037. PubMed ID: 28542359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe.
    Mtapuri-Zinyowera S; Chideme M; Mangwanya D; Mugurungi O; Gudukeya S; Hatzold K; Mangwiro A; Bhattacharya G; Lehe J; Peter T
    J Acquir Immune Defic Syndr; 2010 Sep; 55(1):1-7. PubMed ID: 20622679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of two POC technologies for CD4 count in Morocco.
    Elharti E; Abbadi H; Bensghir R; Marhoum El Filali K; Elmrabet H; Oumzil H
    AIDS Res Ther; 2020 Jun; 17(1):31. PubMed ID: 32522235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa.
    Myer L; Phillips TK; Hsiao NY; Zerbe A; Petro G; Bekker LG; McIntyre JA; Abrams EJ
    J Int AIDS Soc; 2015; 18(1):20045. PubMed ID: 26154734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.
    Makadzange AT; Bogezi C; Boyd K; Gumbo A; Mukura D; Matubu A; Ndhlovu CE
    PLoS One; 2016; 11(7):e0157546. PubMed ID: 27388763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis.
    Vojnov L; Markby J; Boeke C; Harris L; Ford N; Peter T
    PLoS One; 2016; 11(5):e0155256. PubMed ID: 27175484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
    Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
    PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa.
    Stinson K; Boulle A; Coetzee D; Abrams EJ; Myer L
    Trop Med Int Health; 2010 Jul; 15(7):825-32. PubMed ID: 20497405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid point-of-care CD4 testing at mobile units and linkage to HIV care: an evaluation of community-based mobile HIV testing services in South Africa.
    Sloot R; Glenshaw MT; van Niekerk M; Meehan SA
    BMC Public Health; 2020 Apr; 20(1):528. PubMed ID: 32306930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of the Alere PIMA CD4 test for monitoring HIV-infected individuals in resource-constrained settings.
    Sukapirom K; Onlamoon N; Thepthai C; Polsrila K; Tassaneetrithep B; Pattanapanyasat K
    J Acquir Immune Defic Syndr; 2011 Oct; 58(2):141-7. PubMed ID: 21709568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field Performance of PIMA Point-of-Care Machine for CD4 Enumeration Under a Mobile HIV Counseling and Testing Program in Remote Fishing Communities of Lake Victoria, Uganda.
    Namuniina A; Lutwama F; Biribawa VM; Kizza D; Kabuubi BR; Kitandwe PK; Mpendo J; Nanvubya A; Ssempiira J; Nalutaaya A; Ssetaala A; Welsh S; Price MA; Kiwanuka N; Bagaya BS
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):382-387. PubMed ID: 30560683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South Africa.
    Larson BA; Schnippel K; Ndibongo B; Xulu T; Brennan A; Long L; Fox MP; Rosen S
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):e13-7. PubMed ID: 22659650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    Rosen S; Maskew M; Fox MP; Nyoni C; Mongwenyana C; Malete G; Sanne I; Bokaba D; Sauls C; Rohr J; Long L
    PLoS Med; 2016 May; 13(5):e1002015. PubMed ID: 27163694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.